UK to add India’s Covaxin to approved list from Nov 22

0
27

Hyderabad-based pharma major Bharat Biotech’s Covid vaccine Covaxin will be added to the UK government’s approved list of vaccines for international travellers from November 22.

“From 4 a.m. on Monday 22 November, the government will recognise vaccines on the World Health Organisation’s Emergency Use Listing,” said the UK government’s new travel guidelines.

The development has come after the World Health Organisation approved Covaxin for emergency use listing last week.

“From 4 am on Monday 22 November, we will recognise the following vaccines: Pfizer BioNTech, Oxford AstraZeneca (including Covishield), Moderna and Janssen (J&J), and WHO EUL including Sinovac, Sinopharm Beijing and Covaxin,” said the guidelines further.

“Sinovac, Sinopharm Beijing and Covaxin will be added to our list of approved vaccines for inbound travel, benefitting more fully vaccinated people from countries such as the United Arab Emirates, Malaysia and India,” it added further.

This means those vaccinated with the Covaxin will not have to self-isolate after arrival in England. Last month Indian vaccine Covishield was also added to the UK’s approved list.

Alex Ellis, British High Commissioner to India, said, “More good news for Indian travellers to the UK. From 22 November travellers fully vaccinated with a COVID19 vaccine recognised by WHO for Emergency Use Listing, including Covaxin, will not have to self-isolate; so joining those fully vaccinated with Covishield.”

“Today’s announcement is another step forward for the travel industry, businesses and for family and friends wanting to reunite or go abroad,” UK Health Secretary Sajid Javid said.

“The red list and quarantine system remain vital in protecting our borders and as we’ve said we will not hesitate to take action by adding countries to the red list if necessary”, he added further.

The UK government has also simplified the travel rules for all under-18 coming to England. They will now be treated as fully vaccinated at the border and will be exempt from self-isolation requirements on arrival, day-8 testing and pre-departure testing.

Previous articleT20 World Cup: What can we say if players prioritise IPL over country, says Kapil Dev
Next articleMercedes team principal says battle for top position not over yet
Arushi Sana is the Co-Founder of Santerra Living, a bio-pellet factory that makes a renewable form of eco-coal and Co-Founder of NYK Daily, a global news platform. She was awarded the Times Power Women of the Year 2022, Times Digital Entrepreneur of the Year 2023, Silicon India's Top 10 Women Owned Startups of Hyderabad 2023 and IHW Council Climate Health Influencer 2024. Arushi is also a speaker for Sustainability and Entrepreneurship at various forms like the World Bank, UN International Solar Alliance and Universities, and was also invited to the UN COP28 UAE Climate Conference. She is a Sustainability Consultant for organisations looking to reduce their carbon footprint and also works with brands on social media to help them carve a presence in that niche. She holds a Degree in Computer Science Engineering from VIT University and a Diploma in Marketing Analytics from IIM Nagpur. She has previously worked in Ernst & Young and Deloitte as a Forensic Data Analyst. Arushi is a writer, political researcher, a social worker, a farmer and a singer with an interest in languages. Travel and nature are the biggest spiritual getaways for her, and she aims to develop a global community of knowledge and journalism par excellence through this News Platform.

Was it worth reading? Let us know.